GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Abbott Laboratories (ABT) [hlAlert]

Rating:
Outperform
ABT
down 31.76 %

Abbott Laboratories (ABT) rated Outperform by Wells Fargo

Posted on: Friday,  Oct 19, 2012  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Abbott Laboratories (NYSE: ABT) on 10/19/2012, when the stock price was $66.89. Since
then, Abbott Laboratories has lost 31.77% as of 10/07/2015's recent price of $45.64.
If you would have followed this Wells Fargo's recommendation on ABT, you would have lost 31.76% of your investment in 1083 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/19/2012 8:25 AM Buy
None
66.89
as of 12/31/2012
1 Week up  0.04 %
1 Month up  0.76 %
3 Months down  -2.07 %
1 YTD down  -2.07 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy